Synthesis of natural and non natural orthogonally protected lanthionines from N-tritylserine and allo-threonine derivatives

Tetrahedron Asymmetry

Volumn 8, Issue 9, 1997, Pages 1453-1465

  Dugave, Christophe ^a   Ménez, André ^a  

^a CEA SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; LANTHIONINE;

ARTICLE; DRUG PURIFICATION; DRUG SYNTHESIS; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MASS SPECTROMETRY; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; REACTION ANALYSIS; STEREOCHEMISTRY;

EID: 0342710391     PISSN: 09574166     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0957-4166(97)00109-2     Document Type: Article

References (47)

1. Dugave, C.; Ménez, A.; J. Org. Chem. 1996, 61, 6067-6070.
2. (a) Dugave, C.; Kessler, P.; Colas, C.; Hirth, C.; Tetrahedron Lett. 1994, 35, 9199-9202;
3. (b) Cherney, R. J.; Wang, L.; J. Org. Chem. 1996, 61, 2544-2546.
4. For recent reviews see: (a) Jung, G.; Angew. Chem. Int. Ed. Engl. 1991, 30, 1051-1068;
5. (b) Sahl, H.-G.; Jack, R. W.; Bierbaum, G.; Eur. J. Biochem. 1995, 230, 827-853 and references cited therein;
6. (c) Kempter, C.; Kupke, T.; Kaiser, D.; Metzger, J. W.; Jung, G.; for pharmacological application see:
7. (d) Polinsky, A.; Cooney, M. G.; Toy-Palmer, A.; Ösapay, G.; Goodman, M.; J. Med. Chem. 1992, 35, 4185-4194.
8. Parry, R. J.; Naidu, M. V.; Tetrahedron Lett. 1983, 24, 1133-1134.
9. Butera, J.; Rini, J; Helquist, P.; J. Org. Chem. 1985, 50, 3676-3678.
10. (a) Katz, B. A.; Johnson, C. R.; Cass, R. T.; J. Am. Chem. Soc. 19 95, 117, 8541-8547;
11. (b) Zervas, L.; Ferderigos, N.; Israel J. Chem. 1974, 12, 139-152;
12. (c) Ösapay, G.; Zhu, Q.; Shao, H.; Chada, R. K.; Goodman, M.; Int. J. Peptide Protein Res. 1995, 290-301;
13. (d) Shao, H.; Lee, C.-W.; Zhu, Q.; Gantzel, P.; Goodman, M.; Angew. Chem. Int. Ed. Engl. 1996, 35, 90-92.
14. (a) Harp, D. N.; Gleason, G. J.; J. Org. Chem. 1971, 36, 73-80;
15. (b) Olsen, R. K.; Kini, G. D.; Hennen, W. J.; J. Org. Chem. 1985, 50, 4332-4336;
16. (c) Fukase, K.; Wakamiya, T.; Shiba, T.; Bull. Chem. Soc. Jpn. 1986, 59, 2505-2508;
17. (d) Cavelier-Frontin, F.; Daunis, J.; Jacquier, R.; Tetrahedron: Asymmetry 1992, 3, 85-94.
18. (a) Spear, K. L.; Reinhard, E. J.; Mc Mahon, E. G.; Olins, G. M.; Palomo, M. A.; Patton, D. R.; J. Med. Chem. 1989, 32, 67-72;
19. (b) Spear, K. L.; Brown, M. S.; Olins, G. M.; Patton, D. R.; J. Med. Chem. 1989, 32, 1094-1098.
20. (a) Ösapay, G.; Goodman, M.; J. Chem. Soc. Chem. Commun. 1993, 1599-1600;
21. (b) Fukase, K.; Kitasawa, M.; Sano, A.; Shimbo, K.; Fujita, H.; Horimoto, S.; Wakamiya, T.; Shiba, T.; Tetrahedron Lett. 1986, 59, 2505-2508.
22. Photaki, I.; Samouilidis, I.; Caranikas, S.; Zervas, L.; J. Chem. Soc. Perkin Trans. 1979, 2599-2605.
23. Nakajima, K.; Oda, H.; Okawa, K.; Bull. Chem. Soc. Jpn. 1983, 56, 520-522.
24. Shao, H.; Wang, S. H. H.; Lee, C. W.; Ösapay, G., Goodman, M.; J. Org. Chem. 1995, 60, 2956-2957.
25. Pu, Y.; Martin, F. M.; Vederas, J. C.; J. Org. Chem. 1991, 56, 1280-1283 and references cited therein.
26. Kucharczyk, N.; Badet, B.; Le Goffic, F.; Synth. Commun. 1989, 19, 1603-1609.
27. Probert, J. M.; Rennex, D.; Bradley, M.; Tetrahedron Lett. 1996, 37, 1101-1104.
28. 14 c carried out at the 50 mmol scale.
29. Coalescence of distinct signals, initiated above 35°C, could not be completed due to the simultaneous formation of aziridine over 50°C.
30. 1H NMR of sterically hindered α-t-butyl esters of N-tritylglutamates were reported as single rotamers:
31. (b) Baldwin, I.E.; North, M.; Flynn, A.; Moloney, M. G.; Tetrahedron 1989, 45, 1453-1464;
32. (c) ibid. Tetrahedron 1989, 45, 1464-1474; more constrained N-phenylfluorenyl equivalents have been described:
33. (d) Koskinen, A. M. P.; Rapoport, H.; J. Org. Chem. 1989, 54, 1859-1866.
34. We observed that treatment of Boc-Thr(-OMs)-OMe by potassium mercaptoacetate in DMF afforded the corresponding cis-dehydroaminobutyric ester quite quantitatively rather than the corresponding thioacetate.
35. (a) Wakamiya, T.; Shimbo, K.; Shiba, T.; Nakajima, K.; Neya, M.; Okawa, K.; Bull. Chem. Soc. Jpn. 1982, 55, 3878-3881;
36. (b) Baldwin, J. E.; Adlington, R. M.; Moss, N.; Robinson, N. G.; J. Chem. Soc. Chem. Commun. 1987, 1664-1667.
37. 28 after complete deprotection to (S)-2,3-diaminopropionate.
38. (a) Mozingo, R.; Org. Synth. 1941, 21, 15-17;
39. (b) Perlstein, M. T.; Atassi, M. Z.; Cheng, S. G.; Biochim. Biophys. Acta 1971, 236, 174-182;
40. (c) Allgaier, H.; Jung, G.; Werner, R. G.; Schneider U.; Zähner, H.; Angew. Chem. Int. Ed. Engl. 1985, 760, 1051-1053;
41. (d) Allgaier, H.; Jung, G.; Werner, R. G.; Schneider U.; Zähner, H.; Eur. J. Biochem. 1986, 160, 9-22.
42. Einarsson, S.; Josephsson, B.; Möler, P.; Sanchez, D.; Anal. Chem. 1987, 59, 1191-1195.
43. HPLC conditions identical to previous reference: FLEC-Ala (rt=35.63 min (<1%) and 37.38 min (>99%) compared with authentic samples of FLEC-(D,L)-Ala (D: rt=35.52 min, 49%; L: rt=37.18 min, 51%) and FLEC-(L)-Ala (rt=37.40 min, 100%).
44. Goodlett, D. R.; Abuaf, P. A.; Savage, P. A.; Kowalski, K. A.; Mukherjee, T. K.; Tolan, J. W.; Corkum, N.; Goldstein, G.; Crowther, J. B.; J. Chromatogr. 1995, 707, 233-244.
45. Tanaka, T.; Nakajima, K.; Okawa, K.; Bull. Chem. Soc. Jpn. 1980, 53, 1352-1355.
46. No racemization was observed as already reported when 2.4 N sodium hydroxyde is employed as a base.
47. Greenstein, J. P.; Winitz, M.; Chemistry of the Amino Acids 1961, vol. 1, John Wiley & Sons Inc., New York.